MedTrace Logo

Safety and Effectiveness of the Akreos Toric Intraocular Lens.

NCT00825513 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 198

Last updated 2013-03-25

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and effectiveness of the Akreos Toric IOL following cataract surgery.

Conditions

  • Cataract
  • Astigmatism

Interventions

DEVICE

Akreos Toric IOL

Lens implant following cataract surgery

DEVICE

Akreos Advanced Optics Aspheric Intraocular Lens (Akreos AO)

Lens implant following cataract surgery

Sponsors & Collaborators

  • Bausch & Lomb Incorporated

    lead INDUSTRY

Principal Investigators

  • Gabriele Brenger · Bausch & Lomb Incorporated

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2012-03-31
Completion
2012-09-30

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00825513 on ClinicalTrials.gov